XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:              
Net (loss) income $ (73,818) $ (20,259) $ (81) $ 31,455 $ (90,713) $ 37,691  
Adjustments to reconcile net (loss) income to net cash from operating activities              
Share-based compensation         20,286 20,876  
Amortization of intangible assets         15,955 11,063  
Depreciation of property and equipment         6,996 5,269  
Amortization of other assets         1,751 525  
Amortization of debt issuance costs         3,172 3,172  
Syndeo inventory write-down         18,809 0  
Inventory write-down         11,905 5,667  
Provision for estimated credit losses         2,760 1,670  
Change in fair value adjustment of warrant liabilities (5,855)   (4,284)   (8,364) (71,521)  
Other, net         8,897 10,076  
Changes in operating assets and liabilities:              
Accounts receivable         6,007 (40,630)  
Inventories         3,426 (72,129)  
Prepaid expenses, other current assets, and income tax receivable         (16,198) (6,723)  
Accounts payable, other accrued expenses, and income tax payable         50,118 2,012  
Other, net         (7,887) (8,225)  
Net cash provided by (used for) operating activities         26,920 (101,207)  
Cash flows from investing activities:              
Cash paid for intangible assets         (7,084) (4,690)  
Cash paid for property and equipment         (3,797) (9,880)  
Cash paid for asset acquisitions         (18,458) (1,475)  
Net cash used for investing activities         (29,339) (16,045)  
Cash flows from financing activities:              
Payments for repurchase of common stock         0 (80,000)  
Payments for Repurchase of Other Equity         0 (20,000)  
Payment of tax withholdings on vested stock awards         (2,388) 0  
Payment of contingent consideration related to acquisitions         (1,819) (2,763)  
Payment of accelerated share repurchases         (2,240)  
Other, net         356 0  
Net cash used for financing activities         (6,091) (102,763)  
Net decrease in cash and cash equivalents         (8,510) (220,015)  
Effect of foreign currency translation on cash         (243) 2,337  
Cash and cash equivalents, beginning of period   $ 568,197   $ 901,886 568,197 901,886 $ 901,886
Cash and cash equivalents, end of period $ 559,444   $ 684,208   $ 559,444 $ 684,208 $ 568,197